Board Members' Profiles
Evolve Education has an experienced and balanced Board with a diverse range of skills, including industry and business knowledge, financial management and corporate governance experience.
Norah Barlow | Chairperson (Independent)
BCA, CA. Appointed as Director 13 November 2014
Norah is an accountant by profession, operating her own partnership for a number of years, prior to becoming the Group Accountant, and then CEO of NZX and ASX-listed Summerset Group. Norah retired from that role in April 2014 but remains on the Board as a Non-Executive Director.
Norah is now a professional director and holds a number of directorships, including Methven Limited, Cigna Life Insurance New Zealand Limited, Cooks Global Foods Limited and Vigil Monitoring Limited in New Zealand, and Estia Health Limited and Ingenia Communities Limited in Australia. She is also a Ministerial appointee to the National Advisory Council for the Employment of Women, and is Chair of the National Science Challenge ‘Ageing Well’. In 2014 she was awarded an ONZM for services to business.
Norah is Chair of Evolve Education’s Governance and Remuneration Committee and a member of its Audit and Risk Committee.
Mark Finlay | Non-Executive Director (Non-Independent)
BEd. Appointed as Director 13 November 2014
Mark has 13 years’ experience in New Zealand early childhood education. He was a founder and Managing Director of the Lollipops Educare Group. Lollipops Educare is a respected ECE provider in New Zealand having developed and managed more than 40 ECE Centres over the past decade. Mark brings in-depth operational experience in the ECE services industry to the Board.
Mark is a member of Evolve Education’s Governance and Remuneration Committee.
Greg Kern | Non-Executive Director(Non-Independent)
BCom, GradDip in Applied Finance and Investment, CA. Appointed as Director 20 May 2014
Greg is the Managing Director of Kern Group, a corporate advisory firm based in Queensland, Australia. Greg is a chartered accountant, a registered company auditor, a member of the Institute of Internal Auditors and the Australian Institute of Company Directors. Kern Group acted as the lead adviser of the successful listing of Affinity Education Group Limited in Australia. Greg was a promoter of the listing of Affinity Education Group Limited.
Greg is a member of Evolve Education’s Audit and Risk Committee.
Alistair Ryan | Non-Executive Director (Independent)
MCom, CA. Appointed as Director 13 November 2014
Alistair is an experienced company director and corporate executive. He is currently Chairman of NZXlisted investment companies Kingfish Limited, Barramundi Limited and Marlin Global Limited, a Director and Audit and Risk Committee Chair of listed company Metlifecare Limited, a board member and Chair of the Audit and Risk Committee of the New Zealand Racing Board, and a Director of private companies Christchurch Casinos Limited and Lewis Road Creamery Limited. Alistair is also a member of the FMA-appointed Auditor Regulation Advisory Group.
Alistair retired from NZX and ASX-listed SKYCITY Entertainment Group Limited as Chief Financial Officer in June 2011 after a 16-year career with the company, which began just prior to its opening and stock exchange listing in February 1996.
Alistair is the Chair of Evolve Education’s Audit and Risk Committee and a member of its Governance and Remuneration Committee.
Alan Wham | Chief Executive Officer (Non-Independent)
BPharm. Appointed as Director 13 November 2014
Alan was appointed as Chief Executive Officer of Evolve Education with effect from 1 September 2014. Alan was CEO of Pharmacybrands Limited (now Green Cross Health Limited) from late 2003 to mid-2013. The Pharmacybrands business was transformed during this period from a small pharmacy services company to a NZX-listed company with a market capitalisation over $200m. This was achieved by sector consolidation through mergers and acquisitions, raising capital via existing shareholders, delivering significant synergies and enhancing the performance of pharmacy and medical centre acquisitions. Alan was a director of a large number of subsidiary and joint venture companies within the Pharmacybrands group and built strong relationships across the sector.
Since mid-2013 Alan has been active in governance and advisory roles across the broader health arena, including the governance group for the $370m Community Pharmacy Services Agreement. Alan’s early career spanned 15 years in senior executive positions with 3M in New Zealand, the United Kingdom and Australia.
He was Managing Director for 3M Pharma in Australia and Regional Director for Asia Pacific and Africa before returning to New Zealand in late 2003.